CTOs on the Move

Seqirus

www.seqirus.com

 
Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis. In July 2015, the two businesses joined forces to create Seqirus, now the second largest influenza vaccine company in the world. With extensive research and production expertise and manufacturing plants in the US, UK, Germany and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally. Seqirus has a workforce of over 2,000 employees, significant manufacturing capacity and a ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.seqirus.com
  • 475 Green Oaks Parkway
    Holly Springs, NC USA 27540
  • Phone: 919.577.5000

Executives

Name Title Contact Details

Similar Companies

PharmaLinkFHI Inc

PharmaLinkFHI (PharmaLink) is the first full-service Clinical Research Organization (CRO) to integrate clinical and technological expertise in managing Phase I-IV clinical trials online in real time. Biopharmaceutical and medical device organizations

Rib-X Pharmaceuticals

Rib-X Pharmaceuticals, Inc. is a New Haven, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Saranas

Early Bird is the first and only FDA-approved bleed detection system for peri and post-procedural monitoring of endovascular procedures.

Pharmetics

Pharmetics is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.